Latest Insider Transactions at Inovio Pharmaceuticals, Inc. (INO)
This section provides a real-time view of insider transactions for Inovio Pharmaceuticals, Inc. (INO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INOVIO PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INOVIO PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Jong Joseph Kim Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-0.84%
|
-
|
|
Dec 15
2020
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
17,500
-2.07%
|
$175,000
$10.71 P/Share
|
|
Dec 15
2020
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+2.03%
|
$70,000
$4.56 P/Share
|
|
Dec 15
2020
|
Peter Kies CFO |
SELL
Open market or private sale
|
Direct |
20,000
-14.36%
|
$200,000
$10.69 P/Share
|
|
Dec 15
2020
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.93%
|
$40,000
$2.28 P/Share
|
|
Dec 05
2020
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,090
+12.57%
|
-
|
|
Nov 10
2020
|
Laurent Humeau Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,466
-44.28%
|
$175,194
$9.75 P/Share
|